Skip to main content
. Author manuscript; available in PMC: 2024 Feb 1.
Published in final edited form as: Drug Alcohol Depend. 2022 Dec 28;243:109758. doi: 10.1016/j.drugalcdep.2022.109758

Table 7.

Pairwise comparisons: Substance-related problems

(I) Condition*Timepoint Mean Difference (I-J) Std. Error df p
TAU
(Pretreatment)		 Post 17.92 2.31 1 <.001*
FU1 13.85 2.79 1 <.001*
FU3 13.54 2.98 1 <.001*
FU6 14.80 2.66 1 <.001*
FU12 15.04 3.01 1 <.001*
LETS ACT
(Pretreatment)		 Post 19.32 2.18 1 <.001*
FU1 15.11 2.71 1 <.001*
FU3 14.23 2.75 1 <.001*
FU6 16.58 2.09 1 <.001*
FU12 15.48 2.32 1 <.001*
LETS ACT-SE
(Pretreatment)		 Post 17.56 2.47 1 <.001*
FU1 17.82 2.32 1 <.001*
FU3 17.92 2.31 1 <.001*
FU6 13.85 2.79 1 <.001*
FU12 13.54 2.98 1 <.00*
*

Significant at p<.05 level

Note. TAU = Treatment as Usual; LETS ACT = Life Enhancement Treatment for Substance Use; LETS ACT-SE = Life Enhancement Treatment for Substance Use, Smartphone-Enhanced Condition; Post = Posttreatment; FU1 = 1 month follow-up; FU3 = 3 month follow-up; FU6 = 6 month follow-up; FU12 = 12 month follow-up